Results 191 to 200 of about 54,453 (265)

The value of EQ-5D-3L and EQ VAS as a patient-reported outcome measure for patients with ankylosing spondylitis in routine healthcare: an evaluation of construct validity and responsiveness based on the Swedish Rheumatology Quality Register. [PDF]

J Patient Rep Outcomes
Degerlund-Maldi K, Regardt M, Nystrand Länsman C, Larsson L, Parodis I, Heintz E.   +5 more
europepmc   +1 more source

Serum macrophage migration inhibitory factor as a predictor of radiographic progression in ankylosing spondylitis: a retrospective cohort study. [PDF]

Clin Rheumatol
Gazar YAE, Ismail S, Ghanem S, Ghit MM, Azzam AI.   +4 more
europepmc   +1 more source

Incidence and prevalence of immune-mediated extraintestinal manifestations in pediatric inflammatory bowel disease: a systematic review and meta-analysis. [PDF]

Crohns Colitis 360
Colman RJ, Vuyyuru SK, Solitano V, MacDonald JK, Le J, Ricciuto A, Berard R, Mohammed JA, Ma C, Jairath V, Crowley E.   +10 more
europepmc   +1 more source

Renal involvement in ankylosing spondylitis: a retrospective, population-based cohort study using data from the TriNetX Global Network. [PDF]

RMD Open
Tyczyńska KM, Krajewski PK, Świerkot J.   +2 more
europepmc   +1 more source

High-flow nasal oxygen with flexible channel oxygen insufflation for ankylosing spondylitis and cervical fracture-dislocation: a case report and literature review. [PDF]

BMC Anesthesiol
Yu C, Shi Q.
europepmc   +1 more source

Validation of the Dudley inflammatory bowel symptom questionnaire for assessing gastrointestinal symptom burden in axial spondyloarthritis. [PDF]

Rheumatol Int
Ozoglu M, Temiz Karadag D, Gokcen N, Ozdemir Isik O, Yilmaz H, Cefle A, Yazici A.   +6 more
europepmc   +1 more source

Wheelchair to Walking: Quadruple Arthroplasty of Hip and Knee Joints in a Patient with Severe Ankylosing Spondylitis. [PDF]

J Orthop Case Rep
Crossnoe RC, Trivedi VM, DeShazo SJ, Crossnoe RL.   +3 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

THU0198 Risk of Hospitalized Serious Infection in Spondylitis Ankylosing (AS) Patients Using Nbdmard or Anti-TNF

Annals of the Rheumatic Diseases, 2015
Background Nonbiologic Disease-modifying anti-rheumatic drugs (nbDMARDs) and anti-tumor necrosis factor (anti-TNFs) have been used in AS patients who do not respond adequately to non-steroidal anti-inflammatories (NSAIDs). However, concerns exist regarding the risk of serious infections 1 .
C.S. Moura, E. Rahme, W.P. Maksymowych, M. Abrahamowicz, L. Bessette, S. Bernatsky   +5 more
openaire   +1 more source